Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-003512
Filing Date
2021-07-06
Accepted
2021-07-06 17:19:10
Documents
2
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 form3-07062021_020729.html 3  
1 form3-07062021_020729.xml 3 10771
2 ex24-07062021_020729.htm EX-24 3419
  Complete submission text file 0001415889-21-003512.txt   15494
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Issuer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064
Business Address
Morrone Louis H. (Reporting) CIK: 0001867666 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-02189 | Film No.: 211075141